IVERIC bio announced that it is commencing an underwritten public offering of $250M of shares of its common stock. Morgan Stanley, BofA Securities, Cowen and Stifel are acting as the book-running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ISEE: